Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
Saved in:
| Title: | Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial. |
|---|---|
| Authors: | Choueiri TK; Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu., Larkin J; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK., Pal S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, USA., Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Rini BI; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, USA., Venugopal B; Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK., Alekseev B; P. Hertsen Moscow Oncology Research Institute, Moscow, Russia., Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan., Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France., Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA., Hariharan S; Oncology, Pfizer, New York, USA., Chudnovsky A; Oncology, Pfizer, Cambridge, USA., Ching KA; Computational Biology, Pfizer, San Diego, USA., Mu XJ; Computational Biology, Pfizer, San Diego, USA., Mariani M; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy., Robbins PB; Translational Oncology, Pfizer, San Diego, USA., Huang B; Biostatistics, Pfizer, Groton, USA., di Pietro A; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy., Albiges L; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. |
| Source: | ESMO open [ESMO Open] 2021 Jun; Vol. 6 (3), pp. 100101. Date of Electronic Publication: 2021 Apr 23. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
